Skip to main content
Clinical Trials/NCT06411756
NCT06411756
Active, not recruiting
Not Applicable

Physical Activity Intervention Co-created and Tested With African American Colorectal Cancer Survivors

UNC Lineberger Comprehensive Cancer Center1 site in 1 country21 target enrollmentAugust 14, 2024

Overview

Phase
Not Applicable
Intervention
Printed materials
Conditions
Colorectal Neoplasms
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
21
Locations
1
Primary Endpoint
Average weekly steps
Status
Active, not recruiting
Last Updated
15 days ago

Overview

Brief Summary

This research study tests the feasibility of the Physical Activity Centers Empowerment (PACE) physical activity intervention for African American individuals diagnosed with colorectal cancer.

Feasibility will be measured as intervention reach, effectiveness, adoption, implementation, and maintenance. Seventy-two subjects will be recruited to conduct a pilot two-group, randomized repeated measures study.

Detailed Description

The purpose of this research is to improve the quality of life for underserved cancer survivors by increasing physical activity. A physical activity intervention will be tested for feasibility with African American cancer survivors. The project will serve as a foundation for intervening with other underserved cancer survivors. Feasibility will be measured as intervention Reach, Effectiveness, Adoption, Implementation, and Maintenance, following the RE-AIM framework. Survey and biomarker data will be collected at baseline, 3 and 9 months later. These time points will facilitate exploration of changes pre- and post-intervention, and to determine if effects are maintained 6 months after completing the intervention. Our primary hypothesis is that the intervention will be feasible to deliver.

Registry
clinicaltrials.gov
Start Date
August 14, 2024
End Date
June 1, 2026
Last Updated
15 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • self-identifying as AA of Black,
  • diagnosis of CRC,
  • scheduled to receive chemotherapy,
  • age 18 years or older,
  • no contraindications to unsupervised PA as determined by the PA readiness questionnaire,
  • oncologist approval to participate, and
  • a smartphone for Fitbit syncing.

Exclusion Criteria

  • Not provided

Arms & Interventions

Control Arm

Subjects will receive access to the video library after the study period (after the 9-month assessment).

Intervention: Printed materials

Control Arm

Subjects will receive access to the video library after the study period (after the 9-month assessment).

Intervention: Printed materials

Intervention Arm

Subjects will receive access to the video library, a Fitbit, a daily adaptive step goal that will be sent via text message with a short positive message; and monthly Zoom meetings, led by the research team, to discuss physical activity with other study subjects.

Intervention: A Fitbit activity tracker

Intervention Arm

Subjects will receive access to the video library, a Fitbit, a daily adaptive step goal that will be sent via text message with a short positive message; and monthly Zoom meetings, led by the research team, to discuss physical activity with other study subjects.

Intervention: Narrative videos

Intervention Arm

Subjects will receive access to the video library, a Fitbit, a daily adaptive step goal that will be sent via text message with a short positive message; and monthly Zoom meetings, led by the research team, to discuss physical activity with other study subjects.

Intervention: Daily text message

Intervention Arm

Subjects will receive access to the video library, a Fitbit, a daily adaptive step goal that will be sent via text message with a short positive message; and monthly Zoom meetings, led by the research team, to discuss physical activity with other study subjects.

Intervention: Monthly Zoom meeting

Intervention Arm

Subjects will receive access to the video library, a Fitbit, a daily adaptive step goal that will be sent via text message with a short positive message; and monthly Zoom meetings, led by the research team, to discuss physical activity with other study subjects.

Intervention: Website access

Control Arm

Subjects will receive access to the video library after the study period (after the 9-month assessment).

Intervention: A Fitbit activity tracker

Outcomes

Primary Outcomes

Average weekly steps

Time Frame: 3 months

Average weekly steps and the frequency of participants achieving daily step goals. Daily steps are collected via Fitbit Inspire activity tracker. Differences in daily steps and the frequency of meeting daily step goals between the intervention and control arms.

Adaption of the study

Time Frame: Up to 18 months

Adaption of the study will be measured by the percentage of contacted individuals who meet study criteria to participate in the study.

Implementation of using FITBIT

Time Frame: Up to 3 months

Implementation of using FITBIT: The percentage of days that participants wear the study-issued Fitbits.

Implementation of the video library

Time Frame: Up to 3 months

Implementation of the video library: The percentage of participants who watched study-related video content.

Feasibility Retention

Time Frame: 18 months

Retention is measured by the frequency of enrolled participants continued study interventions

Weekly participation in mild, moderate, and vigorous exercise

Time Frame: 3 months

Weekly participation in mild, moderate, and vigorous exercise is time spent on physical activity each week is measured subjectively using the Godin Leisure-time Exercise Questionnaire (GLTEQ) and objectively by the Fitbit Inspire activity tracker. The GLTEQ asks participants to self-report how many times they do strenuous, moderate, and mild or light exercise each week and the average duration of exercise. The intervention effectiveness is operationalized by the differences in minutes of doing mild, moderate, and vigorous physical activity between the intervention and control arms.

The differences between intervention and control arms

Time Frame: 3 months to 9 months

The Maintenance will be measured as the differences in intervention effects between intervention and control arms groups 6 months post-intervention (9 months post-baseline).

Feasibility Reach- Recruitment

Time Frame: 18 months

Feasibility Reach- Recruitment is measured by the number of participants screened, ineligible, eligible, enrolled and declined participation.

Daily engagement in sedentary behaviors

Time Frame: 3 months

Daily engagement in sedentary behaviors will be measured as time spent on sedentary behaviors per day is measured subjectively by a 10-option Likert scale called the Sedentary Behavior Questionnaire. Participants are asked to select one of the following options: none,\<=15 minutes, 30 minutes,1 hour,2 hours,3 hours, 4 hours, 5 hours, and 6 hours or more" to estimate the time they spend doing each sedentary behavior on a typical week and a typical weekend day. The behaviors include watching television, playing computer or video games, sitting and listening to music on the radio, tapes, or CDs, sitting and talking on the phone, doing paperwork or computer work, sitting and reading a book or magazine, playing a musical instrument, doing artwork or crafts, and sitting and driving a car, bus or train. The total daily sedentary score ranges from 0 to 81. Daily sedentary time is also recorded objectively by the Fitbit Inspire activity tracker.

Secondary Outcomes

  • Neurotoxicity(Baseline, 3 months, 9 months)
  • Physical activity engagement(Baseline, 3 months, 9 months)
  • Physical activity enjoyment(Baseline, 3 months, 9 months)
  • Bowel dysfunction score(Baseline, 3 months, 9 months)
  • Inflammation biomarkers level(Baseline, 3 months, 9 months)
  • Self-efficacy(Baseline, 3 months, 9 months)
  • Fatigue score(Baseline, 3 months, 9 months)
  • Sleep quality(Baseline, 3 months, 9 months)
  • Dietary behaviors(Baseline, 3 months, 9 months)
  • Feasibility activity knowledge(Baseline, 3 months, 9 months)
  • Pain score(Baseline, 3 months, 9 months)
  • Depression score(Baseline, 3 months, 9 months)
  • Quality of life score(Baseline, 3 months, 9 months)
  • Outcome expectations(Baseline, 3 months, 9 months)
  • Comorbidities(Baseline, 3 months, 9 months)

Study Sites (1)

Loading locations...

Similar Trials